Potential adverse events in the labeling with the artemis neuro evacuation device include, but are not limited to, hematoma expansion, thromboembolic events, re-bleeding, including death.Therefore, it was determined that the reported adverse events were anticipated complications.The product was not returned for evaluation.From the information provided, there is no indication that there was any device malfunction, nonconformance, or misuse that contributed to the reported event.The manufacturing records for this lot were reviewed and did not reveal any outstanding discrepancies, design, or quality concerns.
|
On (b)(6) 2019, the patient underwent a medical procedure to treat an intracerebral hemorrhage (ich) using an artemis neuro evacuation device (artemis).After blood evacuation with the artemis, evidence of a new ischemic stroke was determined on computerized tomography (ct) scans.Postoperative seizures were likely due to this stroke.In addition, holocephalic left subdural hematoma was likely the cause of the left hemispheric focal status epilepticus.The events were considered unresolved at the time of the study.On (b)(6) 2019, the patient expired from sepsis in the setting of the ich.The patient's death was unrelated to the artemis.The ischemic stroke was adjudicated to be a serious adverse event related to the artemis, the index ich, the index procedure, and comorbidity.The subdural hematoma was adjudicated to be a non-serious adverse event related to the artemis and index procedure.
|